Safety Tolerability & Pharmacokinetics of Co-administered Single Doses of OZ439 & Piperaquine to Healthy Subjects

NCT01660022 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: 100mg OZ439 single oral dose
DRUG: Placebo
DRUG: 300 mg OZ439 single oral dose
DRUG: 160mg Piperaquine single oral dose
DRUG: 480mg Piperaquine single oral dose
DRUG: 1440mg Piperaquine single oral dose
DRUG: 800 mg OZ439 single oral dose

Sponsor

Medicines for Malaria Venture

Collaborators

[object Object]